Table 1.
The clinical and biochemical properties of 40 PAP patients.
| Parameter | PAP (n = 40) |
|---|---|
| Age (year) | 47.70 ± 12.67 |
| Gender (female, no. (%)) | 18 (45.00) |
| Duration of symptoms (months) | 14.69 ± 21.63 |
| Smoking history (current smoking or previous smoking)(Y,%) | 14 (35.00) |
| GM-CSF antibody (μ g/mL) | 27.18 ± 27.56 |
| TC (mmol/L) | 4.20 ± 0.86 |
| TG (mmol/L) | 1.75 ± 1.19 |
| HDL (mmol/L) | 1.15 ± 0.43 |
| LDL (mmol/L) | 2.50 ± 0.75 |
| TC/HDL | 4.07 ± 1.34 |
| LDH (U/L) | 268.23 ± 90.51 |
| CEA (ng/mL) | 3.90 ± 4.33 |
| CYF21-1 (ng/mL) | 9.31 ± 8.08 |
| PaO2 (mmHg) | 69.31 ± 11.49 |
| Alveolar arterial oxygen gradient (A-aDO2) (mmHg) | 34.29 ± 13.48 |
| Disease severity score | 2.63 ± 1.01 |
| FVC%pred | 79.01 ± 17.78 |
| FEV1%pred | 80.19 ± 18.39 |
| DLCO%pred | 60.26 ± 20.90 |
GM-CSF antibody: granulocyte-macrophage colony-stimulating factor antibody; TC: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; LDH: lactate dehydrogenase; CEA: carcinoembryonic antigen; CYFRA21-1: cytokeratin 21-1; PaO2: partial pressure of arterial oxygen; FVC: forced vital capacity; FEV1: forced expiratory volume in one second; DLCO: carbon monoxide diffusion capacity.